Press Releases
These are news releases that are related to our Investor efforts. Releases are listed in chronological order and are archived by year. Sign-up to receive news as it is released using the email and RSS tools below.
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
Jun 3, 2022The studies demonstrated significant improvement in glucose control and reductions in blood pressure for users managing diabetes and hypertension and improvement in clinical measures for users...
- May 19, 2022
Two new B2B contracts reinforce Dario's position as an emerging leader in multi-chronic digital health NEW YORK, May 19, 2022 /PRNewswire/ -- DarioHealth Corp. (NASDAQ: DRIO), a leader in the...
- May 12, 2022
Total Q1 revenue of $8.06 million increased 124% over the comparable prior year period and 34% sequentially over Q4 2021 Accelerated Business-to-Business (B2B) transformation with 14 new B2B...
- May 4, 2022
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the first quarter ended March 31, 2022 on...
- Apr 27, 2022
New research offers fresh evidence that a single digital therapeutics platform can improve outcomes for commonly co-occurring conditions NEW YORK, April 27, 2022 /PRNewswire/ -- DarioHealth Corp....
- Apr 14, 2022
New health plan partnership improves access to digital health for historically underserved populations NEW YORK, April 14, 2022 /PRNewswire/ -- DarioHealth Corp. (Nasdaq: DRIO), a leader in the...
- Mar 23, 2022Dario continues rapid expansion of employer business across multi-condition suite of solutions
DarioHealth Corp. (NASDAQ: DRIO), a leader in the global digital therapeutics (DTx) market, announced today two new employer agreements: first, with a U.S. based social platform employer and...
- Mar 22, 2022Transformational year delivered strong revenue growth of 190% quarter-over-quarter and 171% full year-over-full year
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today reported financial results for the fourth quarter and full year 2021 and provided a corporate and...
- Mar 14, 2022Company to host conference call and webcast on Tuesday, March 22, at 8:30 am ET
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, today announced it would release its financial results for the fourth quarter and full year ended...
- Mar 9, 2022New clients continue Dario's track record of success in winning employer and provider business
DarioHealth Corp. (Nasdaq: DRIO), a leader in the global digital therapeutics (DTx) market, announced today new agreements with a regional employer and a regional provider. The contracts are...